139 related articles for article (PubMed ID: 17557556)
1. Risk of cancer of the prostate and of the kidney parenchyma following bladder cancer.
Fabbri C; Ravaioli A; Ravaioli A; Bucchi L; Balducci C; Canuti D; Desiderio F; Foca F; Panzini I; Falcini F
Tumori; 2007; 93(2):124-8. PubMed ID: 17557556
[TBL] [Abstract][Full Text] [Related]
2. Second primary cancers following cancers of the kidney and prostate in New South Wales (Australia), 1972-91.
McCredie M; Macfarlane GJ; Stewart J; Coates M
Cancer Causes Control; 1996 May; 7(3):337-44. PubMed ID: 8734827
[TBL] [Abstract][Full Text] [Related]
3. Risk of multiple primary cancers in prostate cancer patients in the Detroit metropolitan area: a retrospective cohort study.
Pawlish KS; Schottenfeld D; Severson R; Montie JE
Prostate; 1997 Oct; 33(2):75-86. PubMed ID: 9316648
[TBL] [Abstract][Full Text] [Related]
4. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
5. Risk of Second Primary Cancer among Prostate Cancer Patients in Korea: A Population-Based Cohort Study.
Joung JY; Lim J; Oh CM; Jung KW; Cho H; Kim SH; Seo HK; Park WS; Chung J; Lee KH; Won YJ
PLoS One; 2015; 10(10):e0140693. PubMed ID: 26469085
[TBL] [Abstract][Full Text] [Related]
6. Second primary cancers in men with prostate cancer: an increased risk of male breast cancer.
Thellenberg C; Malmer B; Tavelin B; Grönberg H
J Urol; 2003 Apr; 169(4):1345-8. PubMed ID: 12629357
[TBL] [Abstract][Full Text] [Related]
7. [The risk of second primary neoplasm in prostatic cancer patients].
Osca García JM; Morera Martínez JF; Alfonso Gil R; Catalá Barceló T; Ruiz Cerdá JL; Martínez Jabaloyas JF; Jiménez Cruz JF
Actas Urol Esp; 1993 Oct; 17(9):574-8. PubMed ID: 8165938
[TBL] [Abstract][Full Text] [Related]
8. Global Burden of Urologic Cancers, 1990-2013.
Dy GW; Gore JL; Forouzanfar MH; Naghavi M; Fitzmaurice C
Eur Urol; 2017 Mar; 71(3):437-446. PubMed ID: 28029399
[TBL] [Abstract][Full Text] [Related]
9. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis.
Moschini M; Zaffuto E; Karakiewicz PI; Andrea DD; Foerster B; Abufaraj M; Soria F; Mattei A; Montorsi F; Briganti A; Shariat SF
Eur Urol; 2019 Feb; 75(2):319-328. PubMed ID: 30293908
[TBL] [Abstract][Full Text] [Related]
10. Incidence of kidney, bladder, and prostate cancers in Korea: An update.
Song W; Jeon HG
Korean J Urol; 2015 Jun; 56(6):422-8. PubMed ID: 26078838
[TBL] [Abstract][Full Text] [Related]
11. Risk of second primary Cancer among bladder Cancer patients: a population-based cohort study in Korea.
Kwon WA; Joung JY; Lim J; Oh CM; Jung KW; Kim SH; Seo HK; Park WS; Chung J; Lee KH; Won YJ
BMC Cancer; 2018 May; 18(1):617. PubMed ID: 29855390
[TBL] [Abstract][Full Text] [Related]
12. Double primary cancers of the prostate and bladder: a literature review.
Kinoshita Y; Singh A; Rovito PM; Wang CY; Haas GP
Clin Prostate Cancer; 2004 Sep; 3(2):83-6. PubMed ID: 15479490
[TBL] [Abstract][Full Text] [Related]
13. The risk of bladder cancer in patients diagnosed with other primary neoplasms: analysis of the SEER database.
Anderson JK; Alanee S; Lindgren B; Slaton J
Urol Oncol; 2013 Aug; 31(6):862-5. PubMed ID: 21784673
[TBL] [Abstract][Full Text] [Related]
14. Secular trends of morbidity and mortality of prostate, bladder, and kidney cancers in China, 1990 to 2019 and their predictions to 2030.
Huang Q; Zi H; Luo L; Li X; Zhu C; Zeng X
BMC Cancer; 2022 Nov; 22(1):1164. PubMed ID: 36368976
[TBL] [Abstract][Full Text] [Related]
15. Second primary malignancies associated with renal cell carcinoma: influence of histologic type.
Rabbani F; Reuter VE; Katz J; Russo P
Urology; 2000 Sep; 56(3):399-403. PubMed ID: 10962302
[TBL] [Abstract][Full Text] [Related]
16. Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer.
Chrouser K; Leibovich B; Bergstralh E; Zincke H; Blute M
J Urol; 2005 Jul; 174(1):107-10; discussion 110-1. PubMed ID: 15947588
[TBL] [Abstract][Full Text] [Related]
17. The risk of second malignancies after
Fernandez Ots A; Browne L; Chin YS; Malouf D; Wong K; Bucci J
Brachytherapy; 2016; 15(6):752-759. PubMed ID: 27475483
[TBL] [Abstract][Full Text] [Related]
18. Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.
Liauw SL; Sylvester JE; Morris CG; Blasko JC; Grimm PD
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):669-73. PubMed ID: 16887293
[TBL] [Abstract][Full Text] [Related]
19. Gout patients have an increased risk of developing most cancers, especially urological cancers.
Chen CJ; Yen JH; Chang SJ
Scand J Rheumatol; 2014; 43(5):385-90. PubMed ID: 24825466
[TBL] [Abstract][Full Text] [Related]
20. Occurrence of both bladder and prostate cancer in five cancer registries in Belgium, The Netherlands and the United Kingdom.
Kellen E; Zeegers MP; Dirx M; Houterman S; Droste J; Lawrence G; Truyers C; Bruckers L; Molenberghs G; Joniau S; Buntinx F
Eur J Cancer; 2007 Jul; 43(11):1694-700. PubMed ID: 17531466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
